The 25 thumbs down is very telling. I don't recall having seen such a high number on this board before on a post by a long.
I know this may sound dumb but I couldn't figure out how to access an email address with factspls on it. I have a yahoo email address with my real name on it. Any advice?
Seer could you expand on the tinnitus? I recently came down with it and have been shocked that there are no known cures. It is brutal. Had to give up my Eagles tickets at MSG because of it. ;)
Selling all of my longs and replacing with ultra shorts of the Dow, S&P, and Nasdaq. Thanks for the heads up and detailed analysis.
Then the insulin in the cooler will be free since it was already expensed. That is, of course, assuming Sanofi chooses to use it. Surely you know that opc.
For a quick pick-me-up, just watch Afrezzauser's testimony at AdCom. If I remember correctly he is the first speaker - name is Sam.
Whatever it is, I find it almost impossible to believe that it would be anything that would jeopardize a Q1 2015 intro. FDA approval falls into the realm of jeopardizing a Q1 intro so I just don't see it.
They should check out MNKD. They'd likely find hundreds of buy and sells on a daily basis instigated by a high number of hedge funds.
What, and give everything away to competitors? Have you ever worked on a new product launch? Or in a large corporation? Why do you think companies like Apple are so secretive with their new product pipeline? Kevin, I think you make some great contributions to this board but you are way off base on this one.
I would guess that they have filled the lead with an experienced exec from within Sanofi. At least that is what I would hope and expect.
Terrific post. I hope this answers message board concerns about lack of MNKD PR. I believe I stated just yesterday that PR responsibility would shift to Sanofi. Things are moving along quite nicely.